Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes

Insulin resistance is a hallmark of obesity-associated type 2 diabetes. Insulin's actions go beyond metabolic cells and also involve blood vessels, where insulin increases capillary blood flow and delivery of insulin and nutrients. We show that adrenomedullin, whose plasma levels are increased in obese humans and mice, inhibited insulin signaling in human endothelial cells through protein-tyrosine phosphatase 1B-mediated dephosphorylation of the insulin receptor. In obese mice lacking the endothelial adrenomedullin receptor, insulin-induced endothelial nitric oxide-synthase activation and skeletal muscle perfusion were increased. Treating mice with adrenomedullin mimicked the effect of obesity and induced endothelial and systemic insulin resistance. Endothelial loss or blockade of the adrenomedullin receptor improved obesity-induced insulin resistance. These findings identify a mechanism underlying obesity-induced systemic insulin resistance and suggest approaches to treat obesity-associated type 2 diabetes.

Authors

Institutions

Publication Details

Journal
Science
Published
2025-02-06
DOI
https://doi.org/10.1126/science.adr4731
Citations
38
Primary Topic
Neuropeptides and Animal Physiology
Type
article
Field-Weighted Citation Impact
32.73
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes

Lee S. Weinstein, Diana Campos, Alfredo Martı́nez, Kenneth Anthony Roquid et al.
38 citations
Science
Neuropeptides and Animal Physiology
32.73
article

Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes

Lee S. Weinstein, Diana Campos, Alfredo Martı́nez, Kenneth Anthony Roquid, Shengpeng Wang, Min Chen, Rémy Bonnavion, Mohamad Wessam Alnouri, Miloslav Šanda, Haruya Kawase, Mario Looso, Stefan Offermanns, Haaglim Cho, Chien-Cheng Lai
article en
38 citations

Abstract

Insulin resistance is a hallmark of obesity-associated type 2 diabetes. Insulin's actions go beyond metabolic cells and also involve blood vessels, where insulin increases capillary blood flow and delivery of insulin and nutrients. We show that adrenomedullin, whose plasma levels are increased in obese humans and mice, inhibited insulin signaling in human endothelial cells through protein-tyrosine phosphatase 1B-mediated dephosphorylation of the insulin receptor. In obese mice lacking the endothelial adrenomedullin receptor, insulin-induced endothelial nitric oxide-synthase activation and skeletal muscle perfusion were increased. Treating mice with adrenomedullin mimicked the effect of obesity and induced endothelial and systemic insulin resistance. Endothelial loss or blockade of the adrenomedullin receptor improved obesity-induced insulin resistance. These findings identify a mechanism underlying obesity-induced systemic insulin resistance and suggest approaches to treat obesity-associated type 2 diabetes.

ScienceVol. 387(6734)
Goethe University Frankfurt (DE), National Institutes of Health (US), National Institute of Diabetes and Digestive and Kidney Diseases (US), Max Planck Institute for Heart and Lung Research (DE), First Affiliated Hospital of Xi'an Jiaotong University (CN), German Centre for Cardiovascular Research (DE), Center for Biomedical Research of La Rioja (ES), Cardio-Pulmonary Institute (DE)
Good health and well-being
Openalex Percentile: Top 0%
Neuropeptides and Animal Physiology
32.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.